Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Former Sanofi CEO Viehbacher takes health investment role

Willlead the Bertarelli family's $2bn Gurnet Point Capital fund

- PMLiVE

FDA gives the nod to TMC’s antiplatelet drug

Kengreal approved in the US three months after it got the green light in Europe

- PMLiVE

Ernst & Young launches digital health innovation programme

Let’s Get Digital will also aim to boost use of technology in social care

- PMLiVE

Innovative Medicines Initiative appoints executive director

Pierre Meulien joins from Genome Canada 

GLI names VP of scientific and regulatory affairs

Dr Brian Harvey joins from Pfizer

- PMLiVE

DigitasLBI New York takes top pharma prize at Lions Health

Leo Burnett Mexico and Fcb Inferno pick up theevent's other Grand Prix awards

Bristol-Myers Squibb (BMS) building

BMS’ Opdivo wins anti-PD1 race in Europe

Treatment given the EMA nod of approval for melanoma

China flag thumb

China turns down one of two Sovaldi patents

Advocacy group attempting to block drug in other emerging markets too

Red Door DJM Liberation Unlimited Communique 2014 wins

Health Unlimited is proud sponsor of the two corporate communications categories at this year’s Communiqué Awards.

Over the last five years, Health Unlimited agencies have been shortlisted nearly 40 times, picking up a total of eight Communiqué Awards, which recognise the very best in healthcare communications.

Health Unlimited

- PMLiVE

NICE recommends infliximab biosimilars ahead of Remicade

Newly-acquired Hospira and Napp see their infliximab products backed by the HTA body

- PMLiVE

Helping European cardiologists keep up to date

Research reveals significant local differences in how the future of CME is seen

Coming together

Pharma and medtech are converging to create stronger competitors

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links